SLC4A8 Antibody

What is SLC4A8 and what is its physiological significance?

SLC4A8 (Solute Carrier Family 4 Member 8), also known as NDCBE (Na+-driven Cl-HCO3- exchanger), NBC3, or k-NBC3, is a membrane transporter protein that mediates electroneutral sodium- and carbonate-dependent chloride-HCO3(-) exchange with a Na(+):HCO3(-) stoichiometry of 2:1 . This protein plays several critical physiological roles:

• pH regulation in neurons, which is essential for proper neuronal function

• Sodium reabsorption in the renal cortical collecting ducts, contributing to electrolyte homeostasis

• Interaction with GABAA receptors in the brain, affecting inhibitory signaling

Dysfunction of SLC4A8 has been implicated in various pathologies, including renal tubular acidosis (affecting kidney function) and potentially epilepsy due to its interaction with inhibitory signaling pathways .

What types of SLC4A8 antibodies are currently available for research?

Several types of SLC4A8 antibodies are available for research applications:

Most commercially available antibodies are rabbit polyclonals targeting the N-terminal region of human SLC4A8, with validated cross-reactivity to mouse and rat proteins . These antibodies have been developed using recombinant fusion proteins or synthetic peptides corresponding to specific amino acid sequences of SLC4A8 .

What are the validated applications for SLC4A8 antibodies?

SLC4A8 antibodies have been validated for several experimental applications:

• Western Blotting (WB): The most commonly validated application, with recommended dilutions ranging from 1:500 to 1:2000 . Expected molecular weights are approximately 123 kDa and 78 kDa .

• ELISA: Several antibodies have been validated for enzyme-linked immunosorbent assays for quantitative detection .

• Immunohistochemistry/Immunocytochemistry: Used for localizing SLC4A8 in tissues, particularly in hippocampal pyramidal neurons and cerebellar Purkinje cells .

• Immunoprecipitation: For isolating SLC4A8 protein complexes to study protein-protein interactions, particularly relevant for investigating interactions with GABAA receptors .

What tissues and cell types show significant SLC4A8 expression?

SLC4A8 expression has been documented in specific tissues and cell types:

• Neuronal tissues:

  • Hippocampal pyramidal neurons

  • Cerebellar Purkinje cells

  • Brain tissue generally shows high expression

• Renal tissues:

  • Cortical collecting ducts of the kidney

  • Plays a role in sodium reabsorption in these structures

• Cell lines useful as positive controls:

  • U-87MG (human glioblastoma)

  • SH-SY5Y (human neuroblastoma)

• Other tissues:

  • Mouse lung has been reported as a positive sample

These expression patterns should be considered when designing experiments and selecting appropriate controls for antibody validation.

How should I validate an SLC4A8 antibody for my specific research application?

A comprehensive validation strategy for SLC4A8 antibodies should include:

• Specificity testing:

  • Compare with other closely related SLC4 family members to confirm specificity

  • Test against purified peptides containing the target epitope

  • Use immunodepletion experiments with the immunizing peptide

• Knockout/knockdown controls:

  • Test antibody reactivity in tissues from SLC4A8 knockout mice

  • Compare wild-type and knockout samples using western blot analysis

• Positive control samples:

  • Use tissues/cells known to express SLC4A8 (brain, kidney, U-87MG cell line)

  • Verify the expected molecular weight (typically 123 kDa, 78 kDa)

• Cross-reactivity assessment:

  • Test across species if working with non-human models

  • Confirm reactivity with human, mouse, or rat samples as appropriate

• Application-specific validation:

  • For Western blotting: Optimize protein extraction, gel percentage, and antibody dilution

  • For immunohistochemistry: Determine optimal fixation and antigen retrieval methods

Comprehensive validation ensures reliable results and prevents misinterpretation of data due to non-specific binding or false positives.

What are the optimal Western blotting conditions for detecting SLC4A8?

Based on published protocols and manufacturer recommendations, optimal Western blotting conditions for SLC4A8 detection include:

• Sample preparation:

  • For membrane proteins like SLC4A8, use specialized membrane protein extraction buffers

  • Include protease inhibitors to prevent degradation

  • Positive control samples: U-87MG, SH-SY5Y, mouse brain tissue, rat kidney

• Gel electrophoresis:

  • Use 7.5% gels for optimal separation of high molecular weight proteins

  • Load 30 μg of whole cell lysate per lane

• Transfer and blocking:

  • Use PVDF membrane for optimal protein binding

  • Standard blocking with 5% non-fat milk or BSA in TBST

• Antibody incubation:

  • Primary antibody dilutions:

    • 1:1000 dilution for ab125910

    • 1:500 to 1:2000 for other commercial antibodies

  • Incubate overnight at 4°C for optimal binding

• Detection:

  • Expected band sizes: approximately 123 kDa (full-length) and 78 kDa (potential isoform)

  • Use appropriate secondary antibodies based on host species (typically anti-rabbit IgG)

• Controls:

  • Include positive and negative tissue controls

  • Use appropriate loading controls for normalization

These conditions should be optimized for each specific antibody and sample type to achieve optimal results.

How can I study SLC4A8's role in neuronal pH regulation?

To investigate SLC4A8's role in neuronal pH regulation, consider the following methodological approaches:

• Expression and localization studies:

  • Use immunohistochemistry with validated SLC4A8 antibodies to map expression in neuronal populations

  • Perform co-localization studies with markers for specific neuronal subtypes

  • Examine subcellular localization to determine membrane vs. intracellular distribution

• Functional studies:

  • Use pH-sensitive fluorescent dyes in combination with pharmacological inhibitors

  • Compare pH regulation in wild-type vs. SLC4A8 knockout neurons

  • Examine the effects of altering extracellular sodium, chloride, or bicarbonate on pH recovery

• Interaction with GABAA receptors:

  • Investigate the reported interaction between SLC4A8 and GABAA receptors

  • Use co-immunoprecipitation with SLC4A8 antibodies to confirm protein-protein interactions

  • Study how this interaction affects inhibitory signaling and pH regulation

• Disease model analysis:

  • Examine SLC4A8 expression in models of epilepsy, where its interaction with GABAA receptors may be relevant

  • Correlate changes in SLC4A8 expression with alterations in pH homeostasis and neuronal excitability

• Compensatory mechanisms:

  • Investigate potential compensatory upregulation of other pH regulatory transporters in SLC4A8-deficient neurons

  • Use antibodies against multiple pH regulatory proteins to compare expression patterns

These approaches, combined with electrophysiological techniques, can provide comprehensive insights into SLC4A8's role in neuronal pH homeostasis.

What approaches can I use to study SLC4A8's function in renal sodium transport?

To investigate SLC4A8's role in renal sodium transport, consider these methodological approaches:

• Expression analysis in kidney tissue:

  • Use immunohistochemistry with SLC4A8 antibodies to localize expression in specific nephron segments

  • Quantify expression levels under different physiological conditions using Western blotting

• Functional transport studies:

  • Measure amiloride-resistant, thiazide-sensitive transepithelial NaCl absorption in isolated collecting ducts

  • Compare transport in tissues from wild-type vs. SLC4A8 knockout mice

  • Examine the effects of hydrochlorothiazide (HCTZ) on sodium excretion

• In vivo physiological assessments:

  • Analyze urinary sodium excretion in wild-type vs. SLC4A8-deficient animals

  • Measure blood pressure and electrolyte homeostasis

  • Examine responses to sodium loading or restriction

• Molecular interaction studies:

  • Investigate potential interactions with other sodium transporters in the collecting duct

  • Study phosphorylation regulation of SLC4A8, particularly in response to mineralocorticoid receptor activation

• Pathophysiological models:

  • Examine SLC4A8 expression and function in models of hypertension or renal tubular acidosis

  • Correlate with sodium handling abnormalities

This multi-faceted approach combines molecular, cellular, and physiological techniques to comprehensively characterize SLC4A8's role in renal sodium transport.

How do I troubleshoot inconsistent results when detecting SLC4A8?

When encountering inconsistent results with SLC4A8 detection, consider these troubleshooting strategies:

• Antibody-related factors:

  • Validate antibody specificity using peptide competition and knockout controls

  • Consider using multiple antibodies targeting different epitopes

  • Verify antibody stability and storage conditions

• Sample preparation optimization:

  • For membrane proteins like SLC4A8, extraction methods are critical

  • Include appropriate detergents for membrane protein solubilization

  • Add protease and phosphatase inhibitors to prevent degradation

  • Ensure consistent protein loading across samples

• Tissue-specific considerations:

  • Expression levels vary across tissues; brain and kidney show highest expression

  • Cell-type specific expression within tissues may require enrichment procedures

  • Consider that SLC4A8 may have tissue-specific post-translational modifications

• Technical adjustments:

  • For Western blotting:

    • Optimize gel percentage (7.5% has been reported to work well)

    • Adjust transfer conditions for high molecular weight proteins

    • Test different blocking agents to reduce background

  • For immunohistochemistry:

    • Optimize fixation and antigen retrieval methods

    • Adjust antibody concentration based on expression levels

• Verification approaches:

  • Correlate protein detection with mRNA expression

  • Consider alternative detection methods (mass spectrometry-based approaches)

Systematic troubleshooting using these strategies can help resolve inconsistencies and improve reproducibility.

How can I differentiate between SLC4A8 and other closely related SLC4 family members?

Distinguishing SLC4A8 from other SLC4 family members requires careful experimental design:

• Antibody selection:

  • Use antibodies raised against unique epitopes of SLC4A8

  • Validate specificity against other SLC4 members (especially NBCn1 and NBCn2/NCBE)

  • The N-terminal region of SLC4A8 shows greater sequence divergence from other family members

• Validation using purified proteins:

  • Test antibody reactivity against purified N-terminal peptides of different SLC4 members

  • Published studies have demonstrated that properly validated antibodies can distinguish GST-tagged NDCBE Nt from His-tagged NBCn1-Nt or His-tagged NBCn2-Nt

• Functional characteristics:

  • SLC4A8 has a distinctive Na(+):HCO3(-) stoichiometry of 2:1

  • Its electroneutral sodium- and carbonate-dependent chloride-HCO3(-) exchange function differs from other family members

• Expression pattern analysis:

  • Compare expression patterns with known distributions of other SLC4 members

  • Use multiple antibodies targeting different SLC4 proteins in parallel experiments

• Genetic approaches:

  • Use tissues from specific SLC4 knockout models as controls

  • Consider siRNA knockdown of specific family members to confirm antibody specificity

These approaches can help ensure that observed signals are specific to SLC4A8 and not related family members.

What are the current methodologies for studying SLC4A8 interactions with other proteins?

To investigate SLC4A8's interactions with other proteins, particularly GABAA receptors , consider these methodologies:

• Co-immunoprecipitation (Co-IP):

  • Use validated SLC4A8 antibodies to pull down protein complexes

  • Analyze co-precipitated proteins by Western blotting or mass spectrometry

  • Perform reciprocal Co-IP with antibodies against suspected interaction partners

• Proximity ligation assay (PLA):

  • Visualize protein-protein interactions in situ with high sensitivity

  • Particularly useful for membrane proteins like SLC4A8

  • Provides spatial information about interactions within cells or tissues

• FRET/BRET approaches:

  • Create fluorescent or bioluminescent fusion proteins

  • Measure energy transfer as indication of protein proximity

  • Allows real-time monitoring of dynamic interactions

• Crosslinking mass spectrometry:

  • Chemically crosslink proteins in their native environment

  • Identify direct protein-protein interactions

  • Provides information about interaction interfaces

• Super-resolution microscopy:

  • Examine co-localization at nanoscale resolution

  • Particularly useful for membrane proteins in specific subcellular domains

• Functional interaction studies:

  • Examine how manipulating SLC4A8 affects GABAA receptor function

  • Study pH regulation in the context of GABA signaling

These complementary approaches can provide comprehensive insights into SLC4A8's protein interaction network and its functional significance.

How do I interpret multiple bands in Western blots with SLC4A8 antibodies?

When multiple bands appear in Western blots with SLC4A8 antibodies, consider these interpretative guidelines:

• Expected band patterns:

  • Primary bands at approximately 123 kDa (full-length) and 78 kDa (potential isoform)

  • Verify specificity using knockout controls or peptide competition

• Possible explanations for additional bands:

  • Alternative splicing: SLC4A8 may have multiple splice variants

  • Post-translational modifications: Glycosylation is common for membrane transporters

  • Proteolytic processing: Partial degradation during sample preparation

  • Oligomerization: Incomplete denaturation may show dimers or higher-order structures

• Validation approaches:

  • Compare band patterns across different tissues and cell types

  • Use multiple antibodies targeting different epitopes

  • Perform peptide competition assays to determine which bands are specific

  • Use samples from SLC4A8 knockout animals as negative controls

• Technical considerations:

  • Optimize sample preparation to minimize degradation

  • Adjust gel percentage for better resolution of specific molecular weight ranges

  • Consider gradient gels for simultaneous visualization of high and low molecular weight forms

• Functional relevance:

  • Investigate whether different forms have distinct subcellular localizations

  • Determine if expression patterns of different forms vary across tissues or conditions

Careful interpretation of multiple bands, supported by appropriate controls, can provide insights into the complexity of SLC4A8 expression and processing.

How can I quantitatively analyze SLC4A8 expression levels across experimental conditions?

For rigorous quantitative analysis of SLC4A8 expression:

• Western blot quantification:

  • Use housekeeping proteins or total protein stains as loading controls

  • Ensure signal is within the linear range of detection

  • Use digital imaging systems rather than film for wider dynamic range

  • Normalize SLC4A8 signal to loading control

  • Consider multiple biological and technical replicates

• Control for technical variables:

  • Maintain consistent protocols for sample preparation

  • Process all experimental groups in parallel

  • Use the same antibody lot across experiments when possible

  • Include internal reference samples across blots for inter-blot normalization

• Statistical analysis:

  • Apply appropriate statistical tests based on experimental design

  • Account for multiple comparisons when necessary

  • Report both effect sizes and P-values

  • Consider power analysis to determine adequate sample sizes

• Complementary approaches:

  • Correlate protein expression with mRNA levels using qRT-PCR

  • Consider proteomics approaches for unbiased quantification

  • Validate findings using immunohistochemistry for spatial information

• Data presentation:

  • Present normalized data with appropriate error bars

  • Include representative blot images

  • Clearly state normalization method and statistical approach

This systematic approach enables reliable quantification of SLC4A8 expression changes across experimental conditions.

What experimental approaches can distinguish between changes in SLC4A8 expression versus activity?

Distinguishing between changes in SLC4A8 expression and functional activity requires complementary approaches:

• Expression analysis:

  • Quantify protein levels using validated antibodies via Western blotting

  • Assess subcellular localization using immunohistochemistry or cell fractionation

  • Measure mRNA levels using qRT-PCR

• Functional transport assays:

  • Measure electroneutral sodium- and carbonate-dependent chloride-HCO3(-) exchange activity

  • Use pH-sensitive fluorescent dyes to monitor intracellular pH changes

  • Employ ion-selective electrodes to measure ion fluxes

  • Compare transport rates normalized to protein expression levels

• Post-translational modification analysis:

  • Investigate phosphorylation states that might regulate activity

  • Examine glycosylation patterns that could affect membrane localization

  • Use phospho-specific antibodies if available, or mass spectrometry approaches

• Trafficking studies:

  • Examine membrane insertion versus intracellular retention

  • Use surface biotinylation assays to quantify plasma membrane expression

  • Study co-localization with trafficking regulators

• Correlation analysis:

  • Plot expression levels against functional activity measurements

  • Determine whether changes in function are proportional to expression changes

  • Identify conditions where expression and function are discordant

These approaches can help determine whether observed phenotypes result from alterations in SLC4A8 abundance or changes in the intrinsic activity or regulation of existing transporters.